Wiernik PH - Search Results

1

Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.

Paietta E, Roberts KG, Wang V, Gu Z, Buck GAN, Pei D, Cheng C, Levine RL, Abdel-Wahab O, Cheng Z, Wu G, Qu C, Shi L, Pounds S, Willman CL, Harvey R, Racevskis J, Barinka J, Zhang Y, Dewald GW, Ketterling RP, Alejos D, Lazarus HM, Luger SM, Foroni L, Patel B, Fielding AK, Melnick A, Marks DI, Moorman AV, Wiernik PH, Rowe JM, Tallman MS, Goldstone AH, Mullighan CG, Litzow MR. Paietta E, et al. Among authors: wiernik ph. Blood. 2021 Sep 16;138(11):948-958. doi: 10.1182/blood.2020010144. Blood. 2021. PMID: 33895809 Free PMC article. Clinical Trial.

2

Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene loci.

Paietta E, Van Ness B, Le Beau MM, Bennett J, Cassileth P, Wiernik PH. Paietta E, et al. Among authors: wiernik ph. Cancer Genet Cytogenet. 1992 May;60(1):82-5. doi: 10.1016/0165-4608(92)90238-4. Cancer Genet Cytogenet. 1992. PMID: 1375531

3

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Among authors: wiernik ph. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

4

Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.

Paietta E, Van Ness B, Bennett J, Racevskis J, Gucalp R, Cassileth P, Wiernik PH. Paietta E, et al. Among authors: wiernik ph. Br J Haematol. 1992 Oct;82(2):324-31. doi: 10.1111/j.1365-2141.1992.tb06425.x. Br J Haematol. 1992. PMID: 1419814

5

Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH. Rowe JM, et al. Among authors: wiernik ph. Leukemia. 1992 Nov;6 Suppl 4:75-7. Leukemia. 1992. PMID: 1434840 Clinical Trial. No abstract available.

6

Retinoids in cancer treatment.

Tallman MS, Wiernik PH. Tallman MS, et al. Among authors: wiernik ph. J Clin Pharmacol. 1992 Oct;32(10):868-88. doi: 10.1002/j.1552-4604.1992.tb04633.x. J Clin Pharmacol. 1992. PMID: 1447394 Review.

7

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.

Wiernik PH, Banks PL, Case DC Jr, Arlin ZA, Periman PO, Todd MB, Ritch PS, Enck RE, Weitberg AB. Wiernik PH, et al. Blood. 1992 Jan 15;79(2):313-9. Blood. 1992. PMID: 1730080 Free article. Clinical Trial.

8

Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemia.

Paietta E, Van Ness B, Bennett JM, Pellone C, Billadeau D, Cassileth PA, Wiernik PH. Paietta E, et al. Among authors: wiernik ph. Leuk Res. 1991;15(2-3):149-55. doi: 10.1016/0145-2126(91)90096-c. Leuk Res. 1991. PMID: 1850055

9

Monosomy 7 in multilineage and acute lymphoblastic leukaemia.

Paietta E, Gucalp R, Wiernik PH. Paietta E, et al. Among authors: wiernik ph. Br J Haematol. 1991 Oct;79(2):152-5. doi: 10.1111/j.1365-2141.1991.tb04515.x. Br J Haematol. 1991. PMID: 1958471

10

Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.

Gucalp R, Paietta E, Weinberg V, Papenhausen P, Dutcher JP, Wiernik PH. Gucalp R, et al. Among authors: wiernik ph. Br J Haematol. 1991 May;78(1):48-54. doi: 10.1111/j.1365-2141.1991.tb04381.x. Br J Haematol. 1991. PMID: 2043481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

766 results

Search Page